Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma: A phase I study

被引：0
|
作者：
Siegel, D. S. [1 ,2 ,3 ,4 ,5 ,6 ]
Weber, D. M. [1 ,2 ,3 ,4 ,5 ,6 ]
Mitsiades, C. S. [1 ,2 ,3 ,4 ,5 ,6 ]
Dimopoulos, M. A. [1 ,2 ,3 ,4 ,5 ,6 ]
Harousseau, J. L. [1 ,2 ,3 ,4 ,5 ,6 ]
Rizvi, S. [1 ,2 ,3 ,4 ,5 ,6 ]
Howe, J. [1 ,2 ,3 ,4 ,5 ,6 ]
Reiser, D. [1 ,2 ,3 ,4 ,5 ,6 ]
Anderson, K. C. [1 ,2 ,3 ,4 ,5 ,6 ]
Richardson, P. G. [1 ,2 ,3 ,4 ,5 ,6 ]
机构：
[1] Hackensack Univ, Med Ctr, Hackensack, NJ USA
[2] MD Anderson Canc Ctr, Houston, TX USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Univ Athens, Sch Med, GR-11527 Athens, Greece
[5] Ctr Rene Gauducheau, Saint Herblain, France
[6] Merck & Co Inc, Upper Gwynedd, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8586
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A Phase I Study of Vorinostat in Combination with Lenalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma
    Siegel, David
    Weber, Donna
    Mitsiades, Constantine S.
    Rizvi, Syed
    Garcia-Vargas, Jose
    Howe, Jason
    Reiser, David
    Anderson, Kenneth C.
    Richardson, Paul
    [J]. BLOOD, 2008, 112 (11) : 1270 - 1270
  • [2] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    Siegel, D. S.
    Richardson, P.
    Dimopoulos, M.
    Moreau, P.
    Mitsiades, C.
    Weber, D.
    Houp, J.
    Gause, C.
    Vuocolo, S.
    Eid, J.
    Graef, T.
    Anderson, K. C.
    [J]. BLOOD CANCER JOURNAL, 2014, 4 : e182 - e182
  • [3] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    D S Siegel
    P Richardson
    M Dimopoulos
    P Moreau
    C Mitsiades
    D Weber
    J Houp
    C Gause
    S Vuocolo
    J Eid
    T Graef
    K C Anderson
    [J]. Blood Cancer Journal, 2014, 4 : e182 - e182
  • [4] Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma
    Vesole, David H.
    Bilotti, Elizabeth
    Richter, Joshua R.
    McNeill, Ann
    McBride, Laura
    Raucci, Laura
    Anand, Palka
    Bednarz, Urszula
    Ivanovski, Kristin
    Smith, Judith
    Batra, Veena
    Aleman, Adolfo
    Sims, Taliah
    Guerrero, Laura
    Mato, Anthony
    Siegel, David S.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2015, 171 (01) : 52 - 59
  • [5] Erratum: Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    D S Siegel
    P Richardson
    M Dimopoulos
    P Moreau
    C Mitsiades
    D Weber
    J Houp
    C Gause
    S Vuocolo
    J Eid
    T Graef
    K C Anderson
    [J]. Blood Cancer Journal, 2014, 4 : e202 - e202
  • [6] Combined Vorinostat, Lenalidomide and Dexamethasone Therapy in Patients with Relapsed or Refractory Multiple Myeloma: A Phase I Study
    Siegel, David
    Weber, Donna M.
    Mitsiades, Constantine S.
    Dimopoulos, Meletios A.
    Harousseau, Jean-Luc
    Rizvi, Syed
    Howe, Jason
    Reiser, David
    Byrne, Catriona
    Anderson, Kenneth C.
    Richardson, Paul
    [J]. BLOOD, 2009, 114 (22) : 129 - 129
  • [7] COMBINED VORINOSTAT, LENALIDOMIDE AND DEXAMETHASONE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: A PHASE I STUDY
    Siegel, D.
    Weber, D.
    Mitsiades, C.
    Dimopoulos, M.
    Harousseau, J.
    Rizvi, S.
    Howe, J.
    Reiser, D.
    Anderson, K.
    Richardson, P.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 155 - 155
  • [8] A PHASE I STUDY OF VORINOSTAT, LENALIDOMIDE, AND DEXAMETHASONE FOR RELAPSED AND REFRACTORY MULTPLE MYELOMA
    Richardson, P.
    Weber, D.
    Mitsiades, C.
    Dimopoulos, M.
    Harousseau, J. L.
    Howe, J.
    Graef, T.
    Gause, C.
    Byrne, C.
    Anderson, K.
    Siegel, D.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 155 - 156
  • [9] A phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone (QUAD) in relapsed and/or refractory multiple myeloma (MM).
    Vesole, David H.
    Siegel, David Samuel DiCapua
    Richter, Joshua Ryan
    McNeill, Ann
    Anand, Palka
    Bednarz, Urszula
    Ivanovski, Kristin
    McBride, Laura
    Raucci, Laura
    Batra, Veena
    Aleman, Adolfo
    Sims, Taliah
    Guerrero, Laura
    Smith, Judith
    Mato, Anthony R.
    Bilotti, Elizabeth
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Vorinostat in Combination With Lenalidomide and Dexamethasone in Lenalidomide-Refractory Multiple Myeloma
    Bilotti, Elizabeth
    Vesole, David H.
    McBride, Laura
    Schmidt, Linda
    Gao, Zhijie
    Gilani, Madiha
    McNeill, Ann
    Bednarz, Urszula
    Richter, Joshua
    Mato, Anthony
    Graef, Thorsten
    Siegel, David S.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (10): : 558 - 562
12345